COVID-19-associated fungal infections
Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …
important complication in a substantial number of critically ill, hospitalized patients with …
When uncontrolled diabetes mellitus and severe COVID-19 converge: the perfect storm for mucormycosis
TM John, CN Jacob, DP Kontoyiannis - Journal of fungi, 2021 - mdpi.com
Mucormycosis (MCR) has been increasingly described in patients with coronavirus disease
2019 (COVID-19) but the epidemiological factors, presentation, diagnostic certainty, and …
2019 (COVID-19) but the epidemiological factors, presentation, diagnostic certainty, and …
Coronavirus disease (Covid-19) associated mucormycosis (CAM): case report and systematic review of literature
Abstract Severe coronavirus disease (COVID-19) is currently managed with systemic
glucocorticoids. Opportunistic fungal infections are of concern in such patients. While COVID …
glucocorticoids. Opportunistic fungal infections are of concern in such patients. While COVID …
The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries
M Hoenigl, D Seidel, A Carvalho… - The Lancet …, 2022 - thelancet.com
Reports of COVID-19-associated mucormycosis have been increasing in frequency since
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …
early 2021, particularly among patients with uncontrolled diabetes. Patients with diabetes …
[HTML][HTML] Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP …
Background Microbiological characterisation of co-infections and secondary infections in
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
patients with COVID-19 is lacking, and antimicrobial use is high. We aimed to describe …
[HTML][HTML] Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients—a multinational observational study by the European …
J Prattes, J Wauters, DR Giacobbe… - Clinical Microbiology …, 2022 - Elsevier
Abstract Objectives Coronavirus disease 2019 (COVID-19)-associated pulmonary
aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The …
aspergillosis (CAPA) has emerged as a complication in critically ill COVID-19 patients. The …
COVID-19 and mucormycosis superinfection: the perfect storm
JA Al-Tawfiq, S Alhumaid, AN Alshukairi, MH Temsah… - Infection, 2021 - Springer
Background The recent emergence of the Coronavirus Disease (COVID-19) disease had
been associated with reports of fungal infections such as aspergillosis and mucormycosis …
been associated with reports of fungal infections such as aspergillosis and mucormycosis …
ECMM/ISHAM recommendations for clinical management of COVID‐19 associated mucormycosis in low‐and middle‐income countries
Reports are increasing on the emergence of COVID‐19–associated mucormycosis (CAM)
globally, driven particularly by low‐and middle‐income countries. The recent unprecedented …
globally, driven particularly by low‐and middle‐income countries. The recent unprecedented …
Aspergillosis: epidemiology, diagnosis, and treatment
J Cadena, GR Thompson… - Infectious Disease Clinics, 2021 - id.theclinics.com
Aspergillosis refers to a spectrum of illness that is dependent on host factors and the
immunologic response. Noninvasive forms include allergic bronchopulmonary aspergillosis …
immunologic response. Noninvasive forms include allergic bronchopulmonary aspergillosis …
Pathogenesis of respiratory viral and fungal coinfections
Individuals suffering from severe viral respiratory tract infections have recently emerged as
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …
“at risk” groups for developing invasive fungal infections. Influenza virus is one of the most …